Altrafin AG’s Starbucks SBUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-59,585
Closed -$5.02M 76
2022
Q3
$5.02M Buy
59,585
+1,464
+3% +$124K 3.01% 7
2022
Q2
$4.44M Buy
58,121
+1,800
+3% +$138K 2.39% 16
2022
Q1
$5.12M Buy
56,321
+660
+1% +$62.3K 2.01% 18
2021
Q4
$6.51M Buy
+55,661
New +$6.28M 2.35% 14

Other funds holding SBUX

Altrafin AG's SBUX Position: Q4 2022 in Review

Altrafin AG sold out of Starbucks (SBUX) in Q4 2022, closing a stake of 59,585 shares — an estimated $5.02M sold.

Altrafin AG first reported a position in SBUX in Q4 2021 and held it in 4 quarters. The position peaked at $6.51M in Q4 2021. 2,332 funds tracked by Wall St. Rank hold SBUX as of Q4 2022.

  • Altrafin AG reported no remaining Starbucks position as of Q4 2022 after selling out during the quarter.
  • Altrafin AG sold 59,585 Starbucks shares in Q4 2022, an estimated $5.02M.
  • Altrafin AG first reported a position in Starbucks in Q4 2021 and held it in 4 quarters.
  • Altrafin AG's Starbucks position peaked at $6.51M in Q4 2021.
  • 2,332 funds tracked by Wall St. Rank held Starbucks as of Q4 2022.

Based on Altrafin AG's 13F filing for Q4 2022, filed 17 Feb 2026.